MedPath

Comparison of vaginal Bon Sorkh with clotrimazole on treatment of vulvovaginal candidiasis

Not Applicable
Conditions
Vulvovaginal Candidiasis.
Candidiasis of vulva and vagina
Registration Number
IRCT20161031030595N2
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
100
Inclusion Criteria

They were not at pregnancy.
They had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study

Exclusion Criteria

They had not previously suffered from known medical diseases such as diabetes, immune system attenuating diseases (such as AIDS) or auto-immune diseases, coagulation disorders, and epilepsy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vaginal discharge. Timepoint: Initially, four and eight days after treatment. Method of measurement: Self-administered questionnaire.
Secondary Outcome Measures
NameTimeMethod
Pruritus. Timepoint: Initially, four and eight days after treatment. Method of measurement: Self-administered questionnaire.
© Copyright 2025. All Rights Reserved by MedPath